» Articles » PMID: 22106208

Seasonal Variations in Clostridium Difficile Infections Are Associated with Influenza and Respiratory Syncytial Virus Activity Independently of Antibiotic Prescriptions: a Time Series Analysis in Quebec, Canada

Overview
Specialty Pharmacology
Date 2011 Nov 23
PMID 22106208
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Seasonal variations in Clostridium difficile-associated diarrhea (CDAD), with a higher incidence occurring during winter months, have been reported. Although winter epidemics of respiratory viruses may be temporally associated with an increase in CDAD morbidity, we hypothesized that this association is mainly due to increased antibiotic use for respiratory infections. The objective of this study was to evaluate the effect of the two most frequent respiratory viruses (influenza virus and respiratory syncytial virus [RSV]) and antibiotics prescribed for respiratory infections (fluoroquinolones and macrolides) on the CDAD incidence in hospitals in the province of Québec, Canada. A multivariable Box-Jenkins transfer function model was built to relate monthly CDAD incidence to the monthly percentage of positive tests for influenza virus and RSV and monthly fluoroquinolone and macrolide prescriptions over a 4-year period (January 2005 to December 2008). Analysis showed that temporal variations in CDAD incidence followed temporal variations for influenza virus (P = 0.043), RSV (P = 0.004), and macrolide prescription (P = 0.05) time series with an average delay of 1 month and fluoroquinolone prescription time series with an average delay of 2 months (P = 0.01). We conclude that influenza virus and RSV circulation is independently associated with CDAD incidence after controlling for fluoroquinolone and macrolide use. This association was observed at an aggregated level and may be indicative of other phenomena occurring during wintertime.

Citing Articles

Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research.

Tadesse B, Keddy K, Rickett N, Zhusupbekova A, Poudyal N, Lawley T Clin Infect Dis. 2023; 77(Suppl 7):S597-S607.

PMID: 38118013 PMC: 10732565. DOI: 10.1093/cid/ciad562.


Maternal vitamin D in pregnancy and infant's gut microbiota: a systematic review.

Molani-Gol R, Rafraf M Front Pediatr. 2023; 11:1248517.

PMID: 37915988 PMC: 10617198. DOI: 10.3389/fped.2023.1248517.


A Nonlinear Time-Series Analysis to Identify the Thresholds in Relationships Between Antimicrobial Consumption and Resistance in a Chinese Tertiary Hospital.

Chen S, Li Z, Shi J, Zhou W, Zhang H, Chang H Infect Dis Ther. 2022; 11(3):1019-1032.

PMID: 35290657 PMC: 9124282. DOI: 10.1007/s40121-022-00608-w.


Candida gut colonization, yeast species distribution, and biofilm production in Clostridioides difficile infected patients: a comparison between three populations in two different time periods.

Brunetti G, Giuliani A, Navazio A, Paradisi C, Raponi F, Conti L Braz J Microbiol. 2021; 52(4):1845-1852.

PMID: 34264501 PMC: 8578342. DOI: 10.1007/s42770-021-00512-4.


Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use.

Kullar R, Johnson S, McFarland L, Goldstein E Antibiotics (Basel). 2021; 10(4).

PMID: 33918619 PMC: 8070357. DOI: 10.3390/antibiotics10040408.


References
1.
Dial S, Kezouh A, Dascal A, Barkun A, Suissa S . Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008; 179(8):767-72. PMC: 2553880. DOI: 10.1503/cmaj.071812. View

2.
Bourgault A, Lamothe F, Loo V, Poirier L . In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada. Antimicrob Agents Chemother. 2006; 50(10):3473-5. PMC: 1610058. DOI: 10.1128/AAC.00479-06. View

3.
Rodriguez-Palacios A, Stampfli H, Duffield T, Peregrine A, Trotz-Williams L, Arroyo L . Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis. 2007; 12(11):1730-6. PMC: 3372327. DOI: 10.3201/eid1211.051581. View

4.
Kuijper E, Coignard B, Tull P . Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006; 12 Suppl 6:2-18. DOI: 10.1111/j.1469-0691.2006.01580.x. View

5.
Aldeyab M, Monnet D, Lopez-Lozano J, Hughes C, Scott M, Kearney M . Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother. 2008; 62(3):593-600. DOI: 10.1093/jac/dkn198. View